Under the heading ''Preparation and cultivation of mouse bone marrow-derived mast cells (BMMCs)'', the sentence ''The centrifuged cells were suspended in complete RPMI1640 medium supplemented with 10% FBS, 1 mM non-essential amino acids (Invitrogen), 5 ng/mL recombinant mouse IL-3 (Peprotech, Rocky Hill, NJ, USA), 50 mM 2-mercaptoethanol, 100 IU/mL penicillin, and 100 lg/mL streptomycin'' should be replaced by ''The centrifuged cells were suspended in complete RPMI1640 medium supplemented with 10% FBS, 0.1 mM non-essential amino acids (Invitrogen), 5 ng/mL recombinant mouse IL-3 (Peprotech, Rocky Hill, NJ, USA), 50 lM 2-mercaptoethanol, 100 IU/mL penicillin, and 100 lg/mL streptomycin''.
The corrected version of the Fig. 1 is given below. 
